BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3534737)

  • 1. [Multicenter clinical study and pharmacokinetics of ceftazidime in children and newborn infants].
    Bégué P; Michel B; Chasalette JP; Allouche G; Quinet B
    Pathol Biol (Paris); 1986 May; 34(5):525-9. PubMed ID: 3534737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of ceftazidime in the treatment of 80 infectious episodes in compromised children.
    Viscoli C; Gargani G; Facco F; Mantero E; Tuo P; Giacchino R; Campelli A; Nantron M; Perlino G
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):629-34. PubMed ID: 3908333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Probabilistic treatment with ceftazidime of severe infections in children].
    Bégué P
    Presse Med; 1988 Oct; 17(37):1985-7. PubMed ID: 2973603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftazidime in the therapy of pseudomonal meningitis.
    Marone P; Concia E; Maserati R; Suter F; Minoli L; Andreoni M; Fiori G
    Chemioterapia; 1985 Aug; 4(4):289-92. PubMed ID: 3902257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis.
    Latzin P; Fehling M; Bauernfeind A; Reinhardt D; Kappler M; Griese M
    J Cyst Fibros; 2008 Mar; 7(2):142-6. PubMed ID: 17766190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftazidime treatment of chronic Pseudomonas infection in patients with cystic fibrosis.
    Fluge G; Digranes A; Michalsen H; Stiris T; Bergan T; Qvigstad EK
    Eur J Respir Dis; 1987 Oct; 71(4):239-43. PubMed ID: 3319661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
    Smith BR
    Clin Pharm; 1984; 3(4):373-85. PubMed ID: 6380902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a new aminoglycoside antibiotic in the treatment of infections in neonates, infants, and children.
    Chiu TA; Ayoub EM; Lorber RR; Danzig MR; Norred S
    Clin Ther; 1983; 6(1):94-102. PubMed ID: 6370440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of ceftazidime in severe infections in children. Review of the literature].
    Bégué P; Quinet B
    Presse Med; 1988 Oct; 17(37):1944-7. PubMed ID: 2973592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftazidime in pediatric infections unsuccessfully treated with other antibiotics: an evaluation of its efficacy and tolerability in compromised host.
    Boner AL; Castellani C; Fostini R; Padovani E
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):333-6. PubMed ID: 2942496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of intravenous ceftazidime in childhood infections].
    Kanra G; Gürsavaş M; Aydin M; Cengizlier R; Seçmeer G; Ceyhan M
    Mikrobiyol Bul; 1990 Jul; 24(3):226-36. PubMed ID: 2283973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftazidime in the treatment of acute severe infections in children and adults.
    Păun L; Ceauşu E
    Arch Roum Pathol Exp Microbiol; 1989; 48(2):177-84. PubMed ID: 2699410
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis].
    Canis F; Trivier D; Vic P; Ategbo S; Turck D; Husson MO
    Pathol Biol (Paris); 1998 Jun; 46(6):449-51. PubMed ID: 9769880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary experience with ceftazidime monotherapy in perinatal infection.
    Amato M; Schaad UB
    Helv Paediatr Acta; 1987; 42(4):297-303. PubMed ID: 3127359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Continuous intravenous home treatment of airway infections using ceftazidime administration via portable pump in patients with cystic fibrosis; a multicenter study].
    Bakker W; Vinks AA; Mouton JW; de Jonge P; Verzijl JG; Heijerman HG
    Ned Tijdschr Geneeskd; 1993 Nov; 137(48):2486-91. PubMed ID: 8272124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical results of the treatment of bacterial infections in children with ceftazidime].
    Zoch-Zwierz W; Rudobielska M; Wierciński R; Winiecka W; Tomaszewska B
    Pol Tyg Lek; 1989 Apr; 44(17):390-3. PubMed ID: 2696939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azlocillin with and without an aminoglycoside against respiratory tract infections in children with cystic fibrosis.
    Michalsen H; Bergan T
    Scand J Infect Dis Suppl; 1981; 29():92-7. PubMed ID: 6947408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The treatment of bacterial infections of the lower respiratory tract in childhood. An open comparative study of sulbactam/ampicillin vs. ceftazidime].
    Longo L; Pugliese A; Schiavone R; Fumarola L; Federici S; De Lucia MG; Canale MP
    Clin Ter; 1990 Dec; 135(5):373-7. PubMed ID: 2150368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aztreonam: review of the clinical experience and potential uses in pediatrics.
    Lebel MH; McCracken GH
    Pediatr Infect Dis J; 1988 May; 7(5):331-9. PubMed ID: 3288947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.